Refractory, advanced Mycosis fungoides Not Yet Recruiting Phase 1 Trials for Carfilzomib (DB08889)

Also known as: Refractory advanced Mycosis fungoides / Mycosis fungoides refractory / Refractory Mycosis Fungoides

IndicationStatusPhase
DBCOND0024424 (Refractory, advanced Mycosis fungoides)Not Yet Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03432741Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast CancerTreatment